Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging
- 1 October 2010
- journal article
- case report
- Published by Springer Science and Business Media LLC in Brain Tumor Pathology
- Vol. 27 (2), 81-87
- https://doi.org/10.1007/s10014-010-0275-7
Abstract
Even when we successfully perform a total extirpation of glioblastoma macroscopically, we often encounter tumor recurrence. We examined seven autopsy brains, focusing on tumor cell infiltration in the peripheral zone of a tumor, and compared our findings with the MR images. There has so far been no report regarding mapping of tumor cell infiltration and DNA histogram by flow cytometry, comparing the neuroimaging findings with the autopsy brain findings. The autopsy brain was cut in 10-mm-thick slices, in parallel with the OM line. Tissue samples were obtained from several parts in the peripheral zone (the outer area adjacent to the tumor edge as defined by postcontrast MRI) and then were examined by H&E, GFAP, and VEGF staining. We defined three infiltrating patterns based on number of infiltrated cells as follows: A zone, 100%–60% of the cells infiltrated tumor cells compared with tumor cell density of the tumor mass; B zone, 60%–20%; C zone, 20%–0%. In the autopsy brain, the tumor was easily identified macroscopically. We found that (1) the tumor cells infiltrated the peritumoral area; and (2) tumor cell infiltration was detected over an area measuring from 6 to 14 mm from the tumor border in the A zone. When performing surgery on glioblastoma, a macroscopic total extirpation of the tumor as defined by the contrast-enhanced area in MRI is therefore considered to be insufficient for successfully reducing tumor recurrence.Keywords
This publication has 26 references indexed in Scilit:
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2008
- Glioma Therapy in AdultsThe Neurologist, 2006
- Pathological and clinical features of cystic and noncystic glioblastomasBrain Tumor Pathology, 2006
- Gene Therapy and Targeted Toxins for GliomaCurrent Gene Therapy, 2005
- Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodiumJournal of Neurosurgery, 2003
- Current and future strategies for the treatment of malignant brain tumorsPharmacology & Therapeutics, 2003
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001
- Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Hypofractionation in glioblastoma multiformeRadiotherapy and Oncology, 2000
- Brain TumorsNew England Journal of Medicine, 1991